RedHill Biopharma Signs New $1.8 Million Plus Sales Royalties Middle East Deal For Talicia®

The deal aims to accelerate Talicia's entry into new Middle East markets Under the terms of the agreement RedHill will receive 250,000 upfront payment and 1.3 million in near- term potential milestone payments, as well as tiered royalties up to mid-teens percent on Talicia net sales Talicia is the only FDA-approved all-in-one, low-dose rifabutin-based therapy to address H. pylori antibiotic re ...